HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Coty Targeting White Space In Women’s Prestige Fragrances, Ultra-Premium Scents After Strong FY2023

Executive Summary

Coty Inc. sees opportunities to grow its business in the $24bn prestige female fragrance market and strengthen its play in the ‘ultra-premium’ segment. The firm’s prestige fragrance sales rose 20% like-for-like in the fiscal 2023 fourth quarter ended 30 June, fueling overall net sales growth of 10% for the period.

You may also be interested in...



Arcaea Resurrects Extinct Flowers With First Fragrances Under Future Society Brand; Cosmetics News

Coty and English footballer David Beckham announce a collection of eau de parfums rolling out to US retailers nationwide in January following a debut in JCPenney. Arcaea introduces biotech-based scents capturing the essence of extinct flowers, and Procter & Gamble’s Mielle hair-care brand launches its first ad campaign. More product launch and marketing news.

Coty’s ‘Most Ambitious Fragrance Project To Date’; Head & Shoulders BARE; Cosmetic Launch News

Infiniment Coty Paris, launching globally in 2024, will “be to fragrance what [ultra-premium] Orveda is to skin care,” the company says. P&G touts Head & Shoulders BARE as the first anti-dandruff shampoo with only nine ingredients. More cosmetic launch news.

FDA’s OTC Monograph User Fees Are Existential Threat To Small Contract Manufacturers, Cosmetics Brands

OMUFA reauthorization should include small business considerations for the US FDA’s OTC Monograph Drug User Fee Program, which established in 2020 a ‘one-size-fits-all’ facility and monograph order request user fee system which could lead to more contract manufacturer exits, a manufacturing bottleneck for OTC cosmetic products, and fewer product choices, says IBA.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153953

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel